Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer

ConclusionsFKBP9 may be a cancer promoter that enhances PCa progression, and the level of FKBP9 may be used as an independent precursor of PCa patients.
Source: Pathology Research and Practice - Category: Pathology Source Type: research